-
1
-
-
84905644591
-
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
-
Camenzind E, Boersma E, Wijns W, et al. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. Eur Heart J 2014; 35:1932-48.
-
(2014)
Eur Heart J
, vol.35
, pp. 1932-1948
-
-
Camenzind, E.1
Boersma, E.2
Wijns, W.3
-
2
-
-
84862858272
-
Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after xience v implantation: Results from the 8,061-patient xience v united states study
-
Naidu SS, Krucoff MW, Rutledge DR, et al. Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. JACC Cardiovasc Interv 2012;5:626-35.
-
(2012)
JACC Cardiovasc Interv
, vol.5
, pp. 626-635
-
-
Naidu, S.S.1
Krucoff, M.W.2
Rutledge, D.R.3
-
3
-
-
84918772240
-
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
-
Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014;371:2155-66.
-
(2014)
N Engl J Med
, vol.371
, pp. 2155-2166
-
-
Mauri, L.1
Kereiakes, D.J.2
Yeh, R.W.3
-
4
-
-
84856452781
-
Six-month versus 12-month dual antiplatelet therapy after implantation of drugeluting stents: The efficacy of xience/promus versus cypher to reduce late loss after stenting (excellent) randomized, multicenter study
-
Gwon HC, Hahn JY, Park KW, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drugeluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 2012;125:505-13.
-
(2012)
Circulation
, vol.125
, pp. 505-513
-
-
Gwon, H.C.1
Hahn, J.Y.2
Park, K.W.3
-
5
-
-
84890373385
-
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The optimize randomized trial
-
Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA 2013;310:2510-22.
-
(2013)
JAMA
, vol.310
, pp. 2510-2522
-
-
Feres, F.1
Costa, R.A.2
Abizaid, A.3
-
6
-
-
84867050148
-
A new strategy for discontinuation of dual antiplatelet therapy: The reset trial (real safety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation)
-
Kim BK, Hong MK, Shin DH, et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol 2012;60:1340-8.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 1340-1348
-
-
Kim, B.K.1
Hong, M.K.2
Shin, D.H.3
-
7
-
-
84918810121
-
Second generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: The security randomized clinical trial
-
Colombo A, Chieffo A, Frasheri A, et al. Second generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol 2014;64:2086-97.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. 2086-2097
-
-
Colombo, A.1
Chieffo, A.2
Frasheri, A.3
-
8
-
-
84860135329
-
Short-versus longterm duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial
-
Valgimigli M, Campo G, Monti M, et al. Short-versus longterm duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 2012;125:2015-26.
-
(2012)
Circulation
, vol.125
, pp. 2015-2026
-
-
Valgimigli, M.1
Campo, G.2
Monti, M.3
-
9
-
-
84908060277
-
Shorter (?6 months) versus longer (?12 months) duration dual antiplatelet therapy after drug eluting stents: A meta-analysis of randomized clinical trials
-
April 18 Epub ahead of print
-
Pandit A, Giri S, Hakim FA, Fortuin FD. Shorter (?6 months) versus longer (?12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv 2014 April 18 (Epub ahead of print).
-
(2014)
Catheter Cardiovasc Interv
-
-
Pandit, A.1
Giri, S.2
Hakim, F.A.3
Fortuin, F.D.4
-
10
-
-
84903168112
-
Meta-analysis of randomized clinical trials comparing short-term versus longterm dual antiplatelet therapy following drug-eluting stents
-
El-Hayek G, Messerli F, Bangalore S, et al. Meta-analysis of randomized clinical trials comparing short-term versus longterm dual antiplatelet therapy following drug-eluting stents. Am J Cardiol 2014;114:236-42.
-
(2014)
Am J Cardiol
, vol.114
, pp. 236-242
-
-
El-Hayek, G.1
Messerli, F.2
Bangalore, S.3
|